Armstrong Henry H Associates Inc. Sells 4,952 Shares of Waters Corporation $WAT

Key Points

• Armstrong Henry H Associates Inc. reduced its stake in Waters Corporation by 37.8%, bringing their total shares down to 8,157 after selling 4,952 shares in Q2.
• Waters Corporation's latest earnings report showed a net revenue increase of 8.8% year-over-year, with earnings per share of $2.95, exceeding analysts' expectations.
• Institutional investors hold 94.01% of Waters Corporation's stock, indicating significant institutional interest in the company despite fluctuating price targets from analysts.

Armstrong Henry H Associates Inc. decreased its position in Waters Corporation (NYSE:WAT - Free Report) by 37.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,157 shares of the medical instruments supplier's stock after selling 4,952 shares during the period. Waters makes up approximately 0.3% of Armstrong Henry H Associates Inc.'s holdings, making the stock its 22nd biggest position. Armstrong Henry H Associates Inc.'s holdings in Waters were worth $2,847,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of WAT. Brighton Jones LLC raised its position in Waters by 112.9% in the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier's stock worth $471,000 after buying an additional 673 shares during the last quarter. Cetera Investment Advisers raised its position in Waters by 4.0% in the 4th quarter. Cetera Investment Advisers now owns 4,087 shares of the medical instruments supplier's stock worth $1,516,000 after buying an additional 158 shares during the last quarter. D. E. Shaw & Co. Inc. raised its position in Waters by 94.9% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 9,550 shares of the medical instruments supplier's stock worth $3,543,000 after buying an additional 4,651 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Waters by 0.5% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,762 shares of the medical instruments supplier's stock worth $5,476,000 after buying an additional 71 shares during the last quarter. Finally, OMERS ADMINISTRATION Corp raised its position in Waters by 20.5% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 2,469 shares of the medical instruments supplier's stock worth $916,000 after buying an additional 420 shares during the last quarter. Institutional investors own 94.01% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on WAT shares. Deutsche Bank Aktiengesellschaft set a $315.00 target price on Waters and gave the stock a "hold" rating in a research report on Tuesday, August 5th. Bank of America upped their price target on shares of Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a research report on Thursday, June 26th. Jefferies Financial Group set a $385.00 price target on shares of Waters and gave the company a "buy" rating in a research report on Monday, August 4th. UBS Group reaffirmed a "neutral" rating on shares of Waters in a research report on Tuesday, July 15th. Finally, Robert W. Baird reduced their price target on shares of Waters from $374.00 to $352.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $378.73.

Waters Trading Down 2.3%

WAT stock opened at $295.40 on Friday. The firm has a market cap of $17.58 billion, a PE ratio of 26.64, a price-to-earnings-growth ratio of 2.82 and a beta of 1.07. The firm has a fifty day moving average price of $299.65 and a 200 day moving average price of $333.02. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $423.56. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75.

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. During the same period last year, the company earned $2.63 earnings per share. Waters's revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. Sell-side analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.